Getting off of the OTC is the companies main objective right now to help grow it even bigger than it can on the OTC itself. Having a company on the OTC hinders a lot of incoming monies and thus why the management wants out of this situation.
How will NASDAQ treat us any differently in terms of trading? Unfortunately no real difference other than the pps. Of course without the squeeze the company can get where it needs to and the squeeze is a complete and total bonus round so to speak.
I'm sure you have read Carpe's posts about how you will never see an OTC company doing results like the big boys do. We are destined to be there amongst them.
Well, typing on iPhone and heavily sedated on morphine so I hope I do make sense and not jut rambling on.
News 
Market Data 
Discover 
AI
